Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity

Published:2019-09 Issue: Volume:178 Page:782-801
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Jubo,Li Tinghan,Zhao Tengteng,Wu Tizhi,Liu Chuang,Ding Hong,Li Zhiyu^ORCID,Bian Jinlei^ORCID

Funder

the National Natural Science Foundation of China

the National Natural Science Foundation of Jiangsu Province of China

the “Double First-class” University Project

the State Key Laboratory of Drug Research

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference34 articles.

1. Recent progress of cyclin-dependent kinase inhibitors as potential anticancer agents;Li;Future Med. Chem.,2016

2. Inhibitors of cyclin-dependent kinases as cancer therapeutics;Whittaker;Pharmacol. Ther.,2017

3. Cyclin dependent kinase 9 inhibitors for cancer therapy;Sonawane;J. Med. Chem.,2016

4. Cyclin dependent kinase (CDK) inhibitors as anticancer drugs;Sanchez-Martinez;Bioorg. Med. Chem. Lett,2015

5. Recent development of CDK inhibitors: an overview of CDK/inhibitor co-crystal structures;Cheng;Eur. J. Med. Chem.,2019

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wogonin protects against bleomycin-induced mouse pulmonary fibrosis via the inhibition of CDK9/p53-mediated cell senescence;Frontiers in Pharmacology;2024-07-08

2. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07

3. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation;Scientific Reports;2024-05-02

4. Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications;Journal of Medicinal Chemistry;2024-04-02

5. Design and optimization of selective and potent CDK9 inhibitors with flavonoid scaffold for the treatment of acute myeloid leukemia;European Journal of Medicinal Chemistry;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3